ClinicalTrials.gov
public full text
Public Domain
Safety and Efficacy Evaluation of LX111 Gene Therapy in nAMD Patients
The goal of this study is to evaluate the safety and efficacy of LX111 treatment of nAMD. This study will enroll subjects aged ≥ 50 vears old to receive a single unilateral intravitreal (lVT) injection of LX111 to evaluate its safety and efficacy.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- An Exploratory Clinical Trial Evaluating LX109 Gene Therapy in Patients With nAMD#1373130
- Brolucizumab Treatment Experience Study of Patients With nAMD in UK Routine Clinical Practice#874418
- Study to Assess the Safety, Tolerability, PK and PD of ABX1100#1370650
- Safety, Tolerability and Efficacy Study of TT-173 in Healthy Volunteers After Tooth Extraction#1280065
- Safety and Tolerability of PG110 in Patients With Knee Osteoarthritis Pain#911419
Record · ID 1371984
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive